Bhupesh Sharma Selected Research

Catalase

9/2023	Behavioral and biochemical investigations to explore the efficacy of quercetin and folacin in experimental diabetes induced vascular endothelium dysfunction and associated dementia in rats.
1/2022	Neurobehavioral and neurobiochemical effect of atomoxetine and N-acetylcysteine in streptozotocin diabetes induced endothelial dysfunction and related dementia.
8/2021	Efficacy of Ulinastatin and Sulforaphane Alone or in Combination in Rat Model of Streptozotocin Diabetes Induced Vascular Dementia.
12/2020	Possible involvement of D2/D3 receptor activation in ischemic preconditioning mediated protection of the brain.
11/2016	Neuroprotective Effects of Nicorandil in Chronic Cerebral Hypoperfusion-Induced Vascular Dementia.
9/2016	Selective modulator of cannabinoid receptor type 2 (CB2) against biochemical alterations and brain damage in chronic cerebral hypoperfusion induced vascular dementia.
1/2016	Minocycline ameliorates prenatal valproic acid induced autistic behaviour, biochemistry and blood brain barrier impairments in rats.
1/2016	Antagonism of Endothelin (ETA and ETB) Receptors During Renovascular Hypertension-Induced Vascular Dementia Improves Cognition.
1/2016	Selective Modulator of Cannabinoid Receptor Type 2 Reduces Memory Impairment and Infarct Size During Cerebral Hypoperfusion and Vascular Dementia.
1/2016	Reversal in Cognition Impairments, Cholinergic Dysfunction, and Cerebral Oxidative Stress Through the Modulation of Ryanodine Receptors (RyRs) and Cysteinyl Leukotriene-1 (CysLT1) Receptors.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bhupesh Sharma Research Topics

Disease

27	Inflammation (Inflammations) 01/2024 - 06/2014
20	Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy) 01/2024 - 08/2010
12	Encephalitis (Encephalitis, Rasmussen) 12/2022 - 04/2015
11	Dementia (Dementias) 09/2023 - 03/2008
9	Body Weight (Weight, Body) 09/2023 - 08/2010
9	Cognitive Dysfunction 11/2016 - 08/2010
7	Autistic Disorder (Autism) 03/2023 - 01/2016
7	Hypertension (High Blood Pressure) 06/2022 - 07/2012
7	Alzheimer Disease (Alzheimer's Disease) 01/2019 - 03/2008
6	Autism Spectrum Disorder 10/2021 - 12/2015
5	Renovascular Hypertension (Goldblatt Syndrome) 01/2024 - 04/2015
5	Neuroinflammatory Diseases 03/2023 - 12/2018
5	Infarction (Infarctions) 12/2020 - 01/2016
5	Brain Infarction 09/2016 - 05/2014
5	Memory Disorders (Memory Loss) 01/2015 - 03/2008
3	Brain Diseases (Brain Disorder) 10/2021 - 08/2019
3	Mitochondrial Diseases (Mitochondrial Disease) 01/2016 - 06/2014
2	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 12/2022 - 02/2021
2	Experimental Diabetes Mellitus 01/2022 - 08/2021
2	Brain Ischemia (Cerebral Ischemia) 01/2020 - 01/2014
2	Huntington Disease (Huntington's Disease) 07/2014 - 03/2014
1	Cerebral Infarction 01/2024

Drug/Important Bio-Agent (IBA)

29	Glutathione (Reduced Glutathione)IBA 09/2023 - 06/2011
21	thiobarbituric acidIBA 09/2023 - 06/2011
18	NitratesIBA 01/2024 - 08/2010
18	NitritesIBA 01/2024 - 08/2010
18	Thiobarbituric Acid Reactive SubstancesIBA 09/2023 - 06/2011
16	CatalaseIBA 09/2023 - 05/2014
16	AcetylcholinesteraseIBA 09/2023 - 08/2010
13	Superoxide DismutaseIBA 09/2023 - 05/2014
12	Peroxidase (Myeloperoxidase)IBA 01/2020 - 06/2014
10	CalciumIBA 10/2016 - 01/2015
9	Glucose (Dextrose)FDA LinkGeneric 09/2023 - 08/2010
9	Superoxides (Superoxide)IBA 09/2023 - 06/2011
8	Brain-Derived Neurotrophic Factor (BDNF)IBA 12/2022 - 01/2021
8	Cholinergic Agents (Cholinergics)IBA 11/2016 - 01/2015
7	Valproic Acid (Depakote)FDA LinkGeneric 11/2022 - 12/2015
7	Streptozocin (Streptozotocin)FDA Link 01/2022 - 03/2008
6	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 09/2019 - 06/2013
5	Neuroprotective AgentsIBA 03/2023 - 01/2015
5	vinpocetineIBA 12/2022 - 06/2014
5	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022 - 12/2018
4	EnzymesIBA 09/2023 - 01/2015
4	Transcription Factors (Transcription Factor)IBA 11/2021 - 01/2021
4	Interleukin-6 (Interleukin 6)IBA 09/2019 - 12/2018
4	Interleukin-10 (Interleukin 10)IBA 09/2019 - 12/2018
4	ChloridesIBA 01/2016 - 01/2015
4	agomelatine (S20098)IBA 12/2015 - 07/2014
4	Malondialdehyde (Propanedial)IBA 01/2015 - 05/2014
3	propionic acid (potassium propionate)IBA 03/2023 - 12/2018
3	Ruthenium RedIBA 03/2023 - 01/2016
3	Proteins (Proteins, Gene)FDA Link 12/2022 - 01/2021
3	Synapsins (Synapsin I)IBA 12/2022 - 01/2021
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2021
3	InterleukinsIBA 01/2022 - 01/2021
3	PapaverineIBA 02/2021 - 01/2021
3	Pioglitazone (Actos)FDA Link 09/2019 - 10/2016
3	Nicorandil (SG 75)IBA 11/2016 - 06/2014
3	Cannabinoid Receptors (Cannabinoid Receptor)IBA 09/2016 - 01/2016
3	Donepezil (Aricept)FDA LinkGeneric 04/2015 - 03/2008
3	Desoxycorticosterone Acetate (DOCA)FDA Link 02/2013 - 07/2012
3	Acetates (Acetic Acid Esters)FDA Link 02/2013 - 07/2012
3	Desoxycorticosterone (Deoxycorticosterone)IBA 02/2013 - 07/2012
3	SaltsIBA 02/2013 - 07/2012
2	montelukast (Singulair)FDA Link 01/2024 - 01/2016
2	Folic Acid (Vitamin M)FDA LinkGeneric 09/2023 - 08/2012
2	QuercetinIBA 09/2023 - 06/2022
2	Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA 03/2023 - 10/2016
2	urinastatin (MR 20)IBA 06/2022 - 08/2021
2	Cyclic AMP Response Element-Binding Protein (Cyclic AMP-Responsive DNA-Binding Protein)IBA 01/2022 - 01/2021
2	Therapeutic UsesIBA 09/2019 - 08/2019
2	PPAR gammaIBA 09/2019 - 08/2019
2	Fenofibrate (CiL)FDA LinkGeneric 01/2019 - 12/2018
2	Amyloid (Amyloid Fibrils)IBA 01/2019 - 03/2008
2	triphenyltetrazoliumIBA 11/2016 - 01/2016
2	AcidsIBA 09/2016 - 01/2016
2	Norepinephrine Plasma Membrane Transport Proteins (Norepinephrine Transporter)IBA 01/2016 - 05/2014
2	Bosentan (Tracleer)FDA Link 01/2016 - 09/2014
2	Galactose (Galactopyranose)FDA LinkGeneric 01/2016 - 01/2016
2	Serotonin (5 Hydroxytryptamine)IBA 01/2016 - 04/2015
2	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2016 - 05/2014
2	Endothelins (Endothelin)IBA 01/2016 - 09/2014
2	Melatonin Receptors (Melatonin Receptor)IBA 12/2015 - 04/2015
2	Cholinesterases (Cholinesterase)IBA 01/2015 - 05/2014
2	NF-kappa B (NF-kB)IBA 03/2014 - 10/2012
2	moxonidine (Moxon)IBA 03/2014 - 01/2014
2	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 11/2013 - 02/2013
2	Butyric Acid (Butanoic Acid)IBA 11/2013 - 06/2011
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 06/2013 - 10/2012
2	Lisinopril (Prinivil)FDA LinkGeneric 06/2013 - 10/2012
2	Angiotensin Receptor AntagonistsIBA 06/2013 - 07/2012
2	Telmisartan (Micardis)FDA Link 06/2013 - 07/2012
2	NADPH Oxidases (NAD(P)H oxidase)IBA 02/2013 - 08/2010
2	Cholinesterase Inhibitors (Anticholinesterases)IBA 07/2012 - 03/2008
2	pitavastatin (itavastatin)FDA Link 08/2010 - 03/2008
2	Celecoxib (Celebrex)FDA Link 06/2008 - 03/2008

Therapy/Procedure

3	Surgical Instruments (Clip) 06/2022 - 04/2015
2	Therapeutics 01/2024 - 06/2011
2	Pancreatectomy 10/2016 - 12/2015
2	Ligation 04/2015 - 01/2014